Adam discusses the complexities surrounding finasteride, a drug initially developed for prostate cancer, and its potential side effects. He highlights the long half-life of the drug and how some users may not experience immediate effects, raising questions about delayed reactions. The conversation also touches on the potency of DHT and the personal decision to embrace hair loss rather than risk adverse effects from medication.
